Clinical trial
Checkpoint Inhibitor-induced Liver Injury Study (ChILI)
NCT04476563 is registered in ClinicalTrials.gov with University of Nottingham as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Checkpoint Inhibitor-induced Liver Injury Study (ChILI)
- Lead sponsor
- University of Nottingham
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- October 13, 2020
- Completion date
- June 30, 2026
- Enrollment
- 160 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
immune-mediated hepatitis